Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations

Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations

Lesia V Tchobaniouk,1 Erin E McAllister,2 Danielle L Bishop,3 Rachel M Carpentier,4 Katharine R Heins,4 Robert J Haight,5 Jeffrey R Bishop6,7 1Department of Pharmacy, North Memorial Health Hospital, Robbinsdale, MN, USA; 2Department of Pharmacy, Clement J. Zablocki VA Medical Center, Milwaukee, WI,...

Full description

Bibliographic Details
Main Authors: Tchobaniouk LV, McAllister EE, Bishop DL, Carpentier RM, Heins KR, Haight RJ, Bishop JR
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Patient Preference and Adherence
Subjects:
adherence
long-acting injections
antipsychotic medications
rbp-7000
risperidone
Online Access:https://www.dovepress.com/once-monthly-subcutaneously-administered-risperidone-in-the-treatment--peer-reviewed-article-PPA

Internet

https://www.dovepress.com/once-monthly-subcutaneously-administered-risperidone-in-the-treatment--peer-reviewed-article-PPA

Similar Items